cancer cell-2016-A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
本文檔由 Science 分享于2016-01-13 19:35
暫無(wú)簡(jiǎn)介
下載文檔
收藏